Notably, this data is in agreement with the analysis of G6PD expression in the TCGA cohorts of LIHC, which indicates that G6PD might serve as a prognostic marker for HCC, with higher expression associated with a worse prognosis (Figure 7A). The gene discussed is G6PD; the disease is hepatocellular carcinoma.